Rare diseases
Investigational molecules
Locations
Kifissias Leoforos 27, 115 23 Athens, Greece
Research activity is concentrated in newly diagnosed multiple myeloma, relapsed/refractory multiple myeloma, and first-line treatment settings, with additional interest in patients who have received prior lenalidomide- and proteasome inhibitor-based therapy. Studies also address transplant-ineligible disease and treatment sequencing across early and later lines of care.
Several trials focus on antibody-based and combination approaches in myeloma care, including settings with severe renal impairment and treatment-naïve patients requiring tailored therapeutic options.
Hellenic Society Of Hematology runs clinical trials in conditions such as Plasma cell myeloma, Acute myeloid leukaemia, FLT3 gene mutation, Immune thrombocytopenia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
